Acting Chief Medical Officer

For over 20 years, Sam Teichman, M.D., has been designing and leading clinical research and drug development programs at biotechnology companies. He has held senior executive positions at Genentech, Medco Research (now part of King Pharmaceuticals), Glycomed (now part of Ligand Pharmaceuticals) and, most recently, VP and Chief Development Officer at ARYx Therapeutics. At ARYx, he staffed and led core project teams that accelerated 3 products from Research into Development, filing 2 US INDs enabling clinical testing, all within 18 months, leading to a significant follow-on private financing and a licensing deal. He was also a founder of the international drug development strategic consulting firm, WinPharm Associates.

Dr. Teichman graduated from Columbia University undergraduate and medical schools. He trained in Cardiology at Albert Einstein College of Medicine in New York City. He is Board Certified in Internal Medicine and Cardiology, has more than 40 medical publications, and is a Fellow of both the American College of Physicians and the American College of Cardiology. He was Associate Clinical Professor of Medicine at USCF from 1990-2001.